Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0043 Transporter Info | ||||
Gene Name | ABCA5 | ||||
Transporter Name | ATP-binding cassette sub-family A member 5 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg06001310) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.72E+00 | Statistic Test | p-value:5.14E-08; Z-score:-1.94E+00 | ||
Methylation in Case |
1.68E-01 (Median) | Methylation in Control | 4.56E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.62E+00 | Statistic Test | p-value:1.80E-07; Z-score:-1.64E+00 | ||
Methylation in Case |
3.57E-01 (Median) | Methylation in Control | 5.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg17302455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.92E-06; Z-score:-9.97E-01 | ||
Methylation in Case |
8.46E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of ABCA5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg24127866) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:7.95E-06; Z-score:-1.30E+00 | ||
Methylation in Case |
7.40E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg17302455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:5.37E-05; Z-score:-2.94E+00 | ||
Methylation in Case |
7.52E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.48E+00 | Statistic Test | p-value:5.55E-03; Z-score:-2.25E+00 | ||
Methylation in Case |
5.56E-02 (Median) | Methylation in Control | 8.23E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg06409153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.15E+00 | Statistic Test | p-value:4.93E-05; Z-score:-5.30E+00 | ||
Methylation in Case |
9.95E-02 (Median) | Methylation in Control | 2.14E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of ABCA5 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg10187674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.03E+00 | Statistic Test | p-value:9.93E-04; Z-score:-3.16E+00 | ||
Methylation in Case |
1.02E-01 (Median) | Methylation in Control | 2.08E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.64E+00 | Statistic Test | p-value:2.59E-08; Z-score:1.76E+00 | ||
Methylation in Case |
9.07E-02 (Median) | Methylation in Control | 5.55E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg17302455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:5.30E-07; Z-score:-9.42E-01 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.79E+00 | Statistic Test | p-value:9.87E-05; Z-score:1.14E+00 | ||
Methylation in Case |
3.90E-02 (Median) | Methylation in Control | 2.19E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg24127866) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:2.00E-04; Z-score:9.69E-01 | ||
Methylation in Case |
2.76E-02 (Median) | Methylation in Control | 2.28E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg08197943) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:7.47E-03; Z-score:4.63E-01 | ||
Methylation in Case |
1.80E-02 (Median) | Methylation in Control | 1.63E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg17302455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.85E-05; Z-score:-1.90E+00 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg00803816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:3.22E-02; Z-score:1.04E-01 | ||
Methylation in Case |
9.14E-02 (Median) | Methylation in Control | 8.99E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:3.76E-06; Z-score:-9.05E-01 | ||
Methylation in Case |
8.97E-02 (Median) | Methylation in Control | 1.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg17302455) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.38E-03; Z-score:-4.39E-01 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg07039560) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:4.00E-21; Z-score:2.69E+00 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 5.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of ABCA5 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg11557546) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:2.86E-17; Z-score:-4.69E+00 | ||
Methylation in Case |
3.70E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of ABCA5 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg08411738) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:3.07E-11; Z-score:-2.99E+00 | ||
Methylation in Case |
6.57E-01 (Median) | Methylation in Control | 8.11E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:8.66E-05; Z-score:1.06E+00 | ||
Methylation in Case |
2.44E-01 (Median) | Methylation in Control | 1.90E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg06001310) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:5.96E-03; Z-score:1.04E+00 | ||
Methylation in Case |
4.37E-02 (Median) | Methylation in Control | 3.55E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg10187674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:1.14E-02; Z-score:5.98E-01 | ||
Methylation in Case |
1.89E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in lung adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg09530790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:3.15E-02; Z-score:1.71E+00 | ||
Methylation in Case |
2.20E-01 (Median) | Methylation in Control | 1.72E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in lung adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg06409153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.41E+00 | Statistic Test | p-value:1.92E-03; Z-score:-1.90E+00 | ||
Methylation in Case |
2.62E-01 (Median) | Methylation in Control | 3.68E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in lung adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg10187674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:5.55E-03; Z-score:-1.74E+00 | ||
Methylation in Case |
2.94E-01 (Median) | Methylation in Control | 3.95E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
5'UTR (cg23189044) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.69E+00 | Statistic Test | p-value:1.59E-15; Z-score:-2.33E+00 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 2.86E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in panic disorder | [ 10 ] | |||
Location |
TSS1500 (cg10187674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.53E-01 | Statistic Test | p-value:3.87E-02; Z-score:-3.71E-01 | ||
Methylation in Case |
-3.07E+00 (Median) | Methylation in Control | -2.92E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg00803816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:3.55E-02; Z-score:3.01E-01 | ||
Methylation in Case |
4.48E-02 (Median) | Methylation in Control | 4.29E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in colon adenocarcinoma | [ 12 ] | |||
Location |
1stExon (cg13694749) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:3.04E-05; Z-score:-4.15E+00 | ||
Methylation in Case |
6.17E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCA5 in colon adenocarcinoma | [ 12 ] | |||
Location |
Body (cg00905417) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:5.75E-05; Z-score:-2.93E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCA5 in colon adenocarcinoma | [ 12 ] | |||
Location |
Body (cg14673267) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:1.14E-03; Z-score:-2.32E+00 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 9.41E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCA5 in prostate cancer | [ 13 ] | |||
Location |
3'UTR (cg16038327) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:4.49E-02; Z-score:-2.54E+00 | ||
Methylation in Case |
6.41E-01 (Median) | Methylation in Control | 8.06E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Third ventricle chordoid glioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCA5 in third ventricle chordoid glioma than that in healthy individual | ||||
Studied Phenotype |
Third ventricle chordoid glioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.021335972; Fold-change:-0.298085831; Z-score:-0.932991457 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Posterior fossa ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCA5 in posterior fossa ependymoma than that in healthy individual | ||||
Studied Phenotype |
Posterior fossa ependymoma [ICD-11:2D50.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.94E-119; Fold-change:-0.659182878; Z-score:-4.314305674 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
RELA YAP fusion ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCA5 in rela yap fusion ependymoma than that in healthy individual | ||||
Studied Phenotype |
RELA YAP fusion ependymoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.80E-47; Fold-change:-0.616884535; Z-score:-3.735193305 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Spinal ependymoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCA5 in spinal ependymoma than that in healthy individual | ||||
Studied Phenotype |
Spinal ependymoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:7.55E-21; Fold-change:-0.637107411; Z-score:-2.834198952 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
microRNA |
|||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-335 directly targets ABCA5 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-335 | miRNA Mature ID | miR-335-5p | ||
miRNA Sequence |
UCAAGAGCAAUAACGAAAAAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.